The Discounted Cash Flow (DCF) valuation of Charles River Laboratories International Inc (CRL) is 183.00 USD. With the latest stock price at 157.12 USD, the upside of Charles River Laboratories International Inc based on DCF is 16.5%.
Based on the latest price of 157.12 USD and our DCF valuation, Charles River Laboratories International Inc (CRL) is a buy. buying CRL stocks now will result in a potential gain of 16.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 9.3% | 7.9% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 112.69 - 379.62 | 183.00 |
| Upside | -28.3% - 141.6% | 16.5% |